Last reviewed · How we verify

Levulan — Competitive Intelligence Brief

Levulan (AMINOLEVULINIC ACID) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Optical Imaging Agent. Area: Metabolic.

marketed Optical Imaging Agent Metabolic Small molecule Live · refreshed every 30 min

Target snapshot

Levulan (AMINOLEVULINIC ACID) — Sun Pharma. Levulan accumulates in abnormal skin cells, allowing for visualization and treatment.

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Levulan TARGET AMINOLEVULINIC ACID Sun Pharma marketed Optical Imaging Agent 1999-01-01
Cytalux PAFOLACIANINE On Target Labs marketed Optical Imaging Agent Folate receptor alpha 2021-01-01
submucosal injection of indocyanine green submucosal injection of indocyanine green Fujian Medical University phase 3 Optical imaging agent / surgical tracer

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Optical Imaging Agent class)

  1. On Target Labs · 1 drug in this class
  2. Sun Pharma · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Levulan — Competitive Intelligence Brief. https://druglandscape.com/ci/aminolevulinic-acid. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: